GLP-1 receptor agonist and long-acting basal insulin analog

This page covers all GLP-1 receptor agonist and long-acting basal insulin analog drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting GLP-1R.

Targets

GLP-1R

Phase 3 pipeline (1)

• albiglutide + insulin glargine · GlaxoSmithKline · Diabetes
  Albiglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that enhances glucose-dependent insulin secretion, and insulin glargine is a long-acting basal insulin analog that provides a steady level of insulin throughout the day.